Characteristics and predictors associated with cancer-related fatigue among solid and liquid tumors

[1]  Qinqin Xu,et al.  Development and external validation of a machine learning-based prediction model for the cancer-related fatigue diagnostic screening in adult cancer patients: a cross-sectional study in China , 2023, Supportive Care in Cancer.

[2]  Xi Ke,et al.  Risk factors for cancer-related fatigue in patients with colorectal cancer: a systematic review and meta-analysis , 2022, Supportive Care in Cancer.

[3]  Pritanjali Singh,et al.  Determinants of Cancer-Related Fatigue among Cancer Patients: A Systematic Review , 2022, Journal of palliative care.

[4]  D. Kell,et al.  The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) , 2022, Pharmaceuticals.

[5]  A. Mazul,et al.  Inferior outcomes associated with emergency department presentation for head and neck cancer surgery☆. , 2022, Oral oncology.

[6]  J. Weinstock,et al.  Clinical In-Hospital Outcomes of Acute Myocardial Infarction in Patients With Hematological Malignancies , 2022, Cureus.

[7]  D. Liew,et al.  Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system , 2021, Leukemia Research.

[8]  M. McNeely,et al.  Cancer-related fatigue in head and neck cancer survivors: Energy and functional impacts. , 2020, Cancer treatment and research communications.

[9]  A. Gavin,et al.  Cumulative financial stress as a potential risk factor for cancer-related fatigue among prostate cancer survivors , 2020, Journal of Cancer Survivorship.

[10]  F. Roila,et al.  Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  T. Revenson,et al.  The experience of financial stress among emerging adult cancer survivors , 2020, Journal of psychosocial oncology.

[12]  M. Ahn,et al.  TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  V. Arndt,et al.  The association of cancer‐related fatigue with all‐cause mortality of colorectal and endometrial cancer survivors: Results from the population‐based PROFILES registry , 2019, Cancer medicine.

[14]  Kuhnt Susanne,et al.  Predictors of fatigue in cancer patients: a longitudinal study , 2019, Supportive Care in Cancer.

[15]  C. Escalante,et al.  Cancer-Related Fatigue in Cancer Survivorship. , 2017, The Medical clinics of North America.

[16]  C. Kiserud,et al.  Chronic fatigue in adult cancer survivors. , 2017, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[17]  S. Barclay,et al.  Cancer-Related Fatigue in Adolescents and Young Adults After Cancer Treatment: Persistent and Poorly Managed , 2017, Journal of adolescent and young adult oncology.

[18]  F. Cognetti,et al.  The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice? , 2017, Breast.

[19]  I. Mesters,et al.  Long-term effectiveness and moderators of a web-based tailored intervention for cancer survivors on social and emotional functioning, depression, and fatigue: randomized controlled trial , 2017, Journal of Cancer Survivorship.

[20]  Sarah T. Jewell,et al.  The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review , 2016, Supportive Care in Cancer.

[21]  M. Cadogan,et al.  The cultural constructs of cancer-related fatigue among American Indian cancer survivors , 2016, Supportive Care in Cancer.

[22]  J. Wolchok,et al.  Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  David Cella,et al.  Cancer-Related Fatigue, Version 2.2015. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[24]  J. Vries,et al.  Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry , 2015, Supportive Care in Cancer.

[25]  J. Bower,et al.  Cancer-related fatigue—mechanisms, risk factors, and treatments , 2014, Nature Reviews Clinical Oncology.

[26]  Thomas J. Smith,et al.  The growth of palliative care in the United States. , 2014, Annual review of public health.

[27]  L. Howie,et al.  Early palliative care in cancer treatment: rationale, evidence and clinical implications , 2013, Therapeutic advances in medical oncology.

[28]  Joke Durnez,et al.  Assessing the relationships between health-related quality of life and postoperative length of hospital stay after oesophagectomy for cancer of the oesophagus and the gastro-oesophageal junction. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[29]  G. Bleijenberg,et al.  Development of fatigue in cancer survivors: a prospective follow-up study from diagnosis into the year after treatment. , 2013, Journal of pain and symptom management.

[30]  M. Cadogan,et al.  “Weaving Balance into Life”: Development and cultural adaptation of a cancer symptom management toolkit for Southwest American Indians , 2012, Journal of Cancer Survivorship.

[31]  F. Dimeo,et al.  Cancer-related fatigue: epidemiology, pathogenesis, diagnosis, and treatment. , 2012, Deutsches Arzteblatt international.

[32]  W. Su,et al.  An examination of cancer-related fatigue through proposed diagnostic criteria in a sample of cancer patients in Taiwan , 2011, BMC Cancer.

[33]  You-Gan Wang,et al.  Modeling strategies in longitudinal data analysis: Covariate, variance function and correlation structure selection , 2010, Comput. Stat. Data Anal..

[34]  Witold R. Rudnicki,et al.  Feature Selection with the Boruta Package , 2010 .

[35]  Bruce Ratner,et al.  Variable selection methods in regression: Ignorable problem, outing notable solution , 2010 .

[36]  J. Nazroo,et al.  A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. , 2009, International journal of epidemiology.

[37]  Patrick Royston,et al.  How should variable selection be performed with multiply imputed data? , 2008, Statistics in medicine.

[38]  S. Fosså,et al.  Chronic fatigue and its correlates in long‐term survivors of cervical cancer treated with radiotherapy , 2007, BJOG : an international journal of obstetrics and gynaecology.

[39]  P. Ganz,et al.  Fatigue in long‐term breast carcinoma survivors , 2006, Cancer.

[40]  P. Hall,et al.  Epidemiology of cancer‐related fatigue in the Swedish twin registry , 2005, Cancer.

[41]  Michael K Parides,et al.  Separation of individual‐level and cluster‐level covariate effects in regression analysis of correlated data , 2003, Statistics in medicine.

[42]  G. Bleijenberg,et al.  Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma , 2002, Cancer.

[43]  Eric R. Ziegel,et al.  Generalized Linear Models , 2002, Technometrics.

[44]  Wei Pan,et al.  Goodness‐of‐fit Tests for GEE with Correlated Binary Data , 2002 .

[45]  D. Cella,et al.  Fatigue in cancer patients compared with fatigue in the general United States population , 2002, Cancer.

[46]  G. Lyman,et al.  Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. , 1999, Journal of pain and symptom management.

[47]  J. Friedman.  Multivariate adaptive regression splines , 1990 .

[48]  F. Roila,et al.  [Cancer-related fatigue]. , 2015, Recenti progressi in medicina.

[49]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.